Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,707 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06540872RecruitingPhase 2
Testing New PET/MRI Scan in Large DCIS
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT06541587Recruiting
Smart VR mindfulness for breast cancer patients on chemo
This study tests whether a virtual reality (VR) mindfulness program that responds to your heartbeat can help reduce stress and improve how well chemotherapy works for breast cancer. You will use a special VR headset during your hospital stay.
Taipei, Neihu DistinctAges 18 years+ - NCT06544018Recruiting
Sleep and body clock study for CAPS patients and family members
This study looks at how CAPS (a genetic condition that causes inflammation) affects sleep and daily body rhythms. It compares people with CAPS to healthy family members living in the same home, to understand differences without any treatment being tested.
BronAges 6 years+ - NCT06544265RecruitingPhase 1
SynKIR-310 for advanced B-cell lymphoma
This trial tests a new treatment called SynKIR-310 for people with B-cell non-Hodgkin lymphoma whose cancer has come back or not responded to at least 2 prior treatments. It may be an option if you've already had CAR T-cell therapy or cannot have it.
Denver, ColoradoAges 18 years+ - NCT06544473RecruitingPhase 4
Estrogen pill vs. patch for Turner syndrome
This trial compares oral and transdermal (patch) estrogen to find the right dose for women with Turner syndrome. It aims to see which method works best for hormone replacement.
Aarhus, Aarhus NAges 18–50 - NCT06545331RecruitingPhase 1
A study of XB010 for advanced solid tumors
This trial tests an investigational drug called XB010 for people with solid tumors that have spread or cannot be removed by surgery. It aims to see if XB010 is safe and effective for several cancer types, including lung, breast, head and neck, and esophageal cancers.
Irvine, CaliforniaAges 18 years+ - NCT06545526RecruitingPhase 3
Celecoxib and metformin for familial adenomatous polyposis
This trial tests whether a combination of two drugs, celecoxib and metformin, can prevent the growth of polyps in the colon or duodenum (the first part of the small intestine) in people with familial adenomatous polyposis (FAP). FAP is a condition that causes many polyps to form, raising the risk of cancer. If you have FAP, are between 20 and 55, and have at least 5 polyps that are 2mm or larger, this study may be for you.
SeoulAges 20–55 - NCT06545981Recruiting
Eye blood flow in idiopathic intracranial hypertension
This study looks at how blood flows to the eyes in people with idiopathic intracranial hypertension (IIH), a condition where pressure builds up inside the skull. It compares these patients with healthy volunteers to better understand the disease and could lead to better treatments.
ViennaAges 18–90 - NCT06547307Recruiting
Genes, Caffeine, and Your Endurance
This study looks at how your genes affect your endurance performance after drinking caffeine. You will do a cycling test and provide DNA samples. It might help explain why some people respond differently to caffeine during exercise.
BrnoAges 18–35 - NCT06547515Recruiting
Bone and muscle health after sleeve gastrectomy
This study looks at how sleeve gastrectomy surgery affects bone and muscle health in men and women at different life stages (before and after menopause). It compares people having the surgery with those who qualify but don't have it.
QuébecAges 18 years+ - NCT06549348Recruiting
Aortic repair study using less radiation
This study tests a new way to guide a complex aortic surgery (fenestrated endovascular repair) using less or no radiation. It may help people with aneurysms who need repair involving the arteries that supply the liver, gut and kidneys.
Birmingham, AlabamaAges 18 years+ - NCT06549179Recruiting
Testing a tool to diagnose autism in adults
This study tests a new French questionnaire (AMSE) to see how well it can identify autism in adults who are seeking a first diagnosis. It may help you get a clearer answer about whether you have autism.
ParisAges 18 years+ - NCT06550674Recruiting
Genetic study for uveal melanoma risk
This study looks for new inherited genes linked to uveal melanoma (an eye cancer). If you have this cancer and don't already have a known genetic cause, you may be able to help find new genes that affect cancer risk.
Clermont-Ferrand, Puy-de-DômeAges 18 years+ - NCT06551220Recruiting
T-DXd for advanced breast cancer with various HER2 levels
This study looks at how well the drug T-DXd (Enhertu) works against breast cancer that has spread or can't be removed with surgery. It includes patients with any level of HER2 protein, so it might be an option even if your cancer has low HER2.
New Haven, ConnecticutAges 18–80 - NCT06551857Recruiting
How cancer treatments affect hearing and thinking
This study looks at how common cancer treatments (certain chemotherapies and radiation to the head and neck) affect hearing in noisy places, thinking skills, and quality of life related to hearing. It aims to understand and possibly reduce these side effects.
Turku, Southwest FinlandAges 18–75 - NCT06553235Recruiting
App-based sleep and memory help for breast cancer survivors
This study tests whether an app-based program can improve sleep and thinking problems (like concentration and memory) in people who finished breast cancer treatment 1-5 years ago. If you have trouble sleeping and/or notice changes in your memory or focus, this trial may be able to help.
Aarhus NAges 18 years+ - NCT06553989Recruiting
Osteopathic care after endometriosis surgery
This trial tests if gentle osteopathic movements to the abdomen can improve quality of life after surgery for deep endometriosis. It may help with pain and recovery.
Clermont-FerrandAges 18 years+ - NCT06555042Recruiting
Crohn's disease imaging study with PET-MRI
This study uses a special PET-MRI scan to look at inflammation and blood flow in the small intestine of people with Crohn's disease. It may help doctors better understand disease activity in the gut.
Turku, Southwest FinlandAges 18–70 - NCT06555107Recruiting
Pain before emergency surgery and long-term pain after
This study looks at whether pain you feel before emergency surgery affects long-term pain after the surgery. It may help doctors find ways to prevent chronic pain in patients who have emergency orthopedic (bone/joint) or abdominal (belly) surgery.
AmiensAges 18 years+ - NCT06555588Recruiting
Supportive talk therapy for advanced cancer symptoms
This study tests a supportive talk therapy program (called Engage) delivered via video calls. It aims to help people with advanced cancer manage tough symptoms like pain, fatigue, and distress and improve daily functioning.
Durham, North CarolinaAges 18 years+ - NCT06557265RecruitingPhase 1/Phase 2
NKX019 for lupus kidney disease or membranous nephropathy
This trial tests an experimental cell therapy called NKX019 for people with active lupus nephritis (a type of kidney inflammation from lupus) or primary membranous nephropathy (another kidney condition) that hasn't gotten better after standard treatments. It may help if you have tried at least two treatments for lupus kidney disease or one for membranous nephropathy and still have active kidney disease.
Little Rock, ArkansasAges 18–75 - NCT06558773RecruitingPhase 2
New drug combo for previously treated colorectal cancer
This trial tests a combination of a GSL synthesis inhibitor, an immunotherapy drug, and/or regorafenib in people with a specific type of colorectal cancer (pMMR/MSS) that has not responded to at least two prior treatments. The goal is to see if this new approach can help shrink or control the cancer.
Beijing, Biotherapeutic Department of Chinsese PLA Gereral HospitalAges 18–75 - NCT06559059Recruiting
Virtual cancer program for Veterans with new cancer
This study looks at how well a virtual (telemedicine) cancer program works for Veterans who are newly diagnosed with lung, prostate, breast, or colon cancer. Participation involves a telemedicine visit at a VA medical center instead of traveling to the hospital.
Brooklyn, New YorkAges 18 years+ - NCT06559696RecruitingPhase 3
Radiation to internal mammary lymph nodes for high-risk breast cancer after chemo
This trial tests whether giving radiation to the internal mammary lymph nodes (the lymph nodes behind your breastbone) can help women with high-risk breast cancer after they have had chemotherapy before surgery. It is for people whose cancer has spread to nearby lymph nodes despite chemotherapy.
Fuzhou, FujianAges 18–75
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,707 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.